Presentation + Paper
14 March 2023 Higher density of ECM composition in pancreatic cancer correlates with reduced drug delivery
Cody C. Rounds, Sanzida Haque, Chengyue Li, Devin Nissen, Dhruv Ranjan, Marcella Vaicik, Rama S. Madhurapantula, Thomas C. Irving, Kenneth M. Tichauer
Author Affiliations +
Abstract
Pancreatic ductal adenocarcinomas (PDACs) are often treatment resistant, and as such widefield imaging methods for the evaluation of ECM composition are needed. Here we present a method to measure the relative abundance of ECM diffracting components in PDAC samples alongside drug penetration in widefield images. Orthotopic mouse PDAC xenografts are grown and assessment of drug penetration as well as ECM composition is done using co-registration of scanning x-ray diffraction (XRD) and EGFR-specific drug penetration fluorescent widefield images. Preliminary data suggests a strongly negative correlation between abundance of diffracting ECM components and penetration of large drugs in solid tumors. This methodology may be used to provide crucial insights into both drug-development approaches and multi-therapeutic treatment strategies in late stage PDAC patients presenting with ECM desmoplasia.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Cody C. Rounds, Sanzida Haque, Chengyue Li, Devin Nissen, Dhruv Ranjan, Marcella Vaicik, Rama S. Madhurapantula, Thomas C. Irving, and Kenneth M. Tichauer "Higher density of ECM composition in pancreatic cancer correlates with reduced drug delivery", Proc. SPIE 12357, Visualizing and Quantifying Drug Distribution in Tissue VII, 123570B (14 March 2023); https://doi.org/10.1117/12.2650840
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

X-ray diffraction

Collagen

Diffraction

Pancreatic cancer

Tissues

Diseases and disorders

Back to Top